🇺🇸 FDA
Pipeline program

tulisokibart, Placebo to MK-7240 (tulisokibart)

MK-7240-014

Phase 2 small_molecule active

Quick answer

tulisokibart, Placebo to MK-7240 (tulisokibart) for Rheumatoid Arthritis is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).

Program details

Company
Merck Sharp and Dohme
Indication
Rheumatoid Arthritis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials